Moreover, low expression of Slit2 or Robo1 in breast cancer patients correlated with poor OS and DFS, suggesting Slit2/Robo1 axis can serve as a prognostic biomarker of breast cancer. This evidence concerns the gene ROBO1 and breast carcinoma.